English | Español

Merck
Carol Ostrow | May 16, 2018

FDA accepts two new drug applications for Merck HIV-1 therapy
Marian Johns | Jan 17, 2018

FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow | Oct 15, 2017

Merck KGaA aims raise awareness, boost support for unpaid caregivers
Carol Ostrow | Oct 1, 2017

Merck to host meeting on third-quarter performance
Russell Boniface | Sep 13, 2017

Merck's Keytruda wins European approval as bladder cancer treatment

Robert Hadley | Jun 16, 2017

Merck’s Keytruda shown effective in treating aggressive form of breast cancer
Tabitha Fleming | Jun 2, 2017

Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe

Trending
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+ Pharmaceuticals
Patient Daily | Apr 22, 2025

National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

State Sen. Baldacci: 340B reform ‘could help hospitals alone to the tune of 50 to 70 million per year'